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Abstract: The use of quercetin as a bioflavonoid is becoming increasingly common in food industries even though poor water solubility,
instability, absorption, and permeability have limited its application. The oil-in-water single-emulsion solvent evaporation method
to synthesize highly stable and soluble quercetin-encapsulated nanoparticles (NPs), in which the reaction yield, particle size, and
polydispersity of the NPs are varied greatly within the process parameters of the synthesis method, has been optimized. NPs with
different initial quercetin amounts were used to determine how the quercetin amount affected nanoparticle properties and antimicrobial
efﬁciency. Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, and Staphylococcus aureus were chosen as model bacteria
due to their being foodborne pathogens. The results of antimicrobial activity evaluated by three different methods showed that the
antimicrobial activity of both quercetin NPs and free quercetin was effective on gram-positive strains (L. monocytogenes and S. aureus).
Additionally, it was detected that Q31 NPs have more effective antimicrobial activity than other synthesized quercetin nanoparticles
depending on the amount of substance and release. Furthermore, on the basis of assessing the antibacterial effects by scanning electron
microscopy, it was detected that bacteria cells lost their integrity and became pale with the release of cytoplasm and decomposed after
treatment with Q31 NPs.
Key words: Antimicrobial activity, nanoparticle, pathogens, PLGA, quercetin

1. Introduction
Quercetin (3,3,4,7-pentahydroxyflavone), a well-known
bioflavonoid, has generated considerable interest within
the food and drug industries due to its beneficial properties
including antioxidant, antiinflammatory, antimutagenic,
anticarcinogenic, antibacterial, and antiviral effects
(Budhian et al., 2007; Bhutada et al., 2010; Kumari et al.,
2010a; Chitkara et al., 2012). It is found abundantly in fruits
and vegetables that are essential parts of the human diet
(Chen et al., 2010; Kumari et al., 2010a; Nathiya et al., 2014).
Notwithstanding this wide spectrum of phytochemical
properties, poor water solubility, absorption, permeability,
instability, and light-induced decomposition of quercetin
limit its use in food formulations (Kumari et al., 2010a).
Moreover, direct application in food matrices generally
results in reduced activity because of its interactions with
other components such as proteins and lipids. Therefore,
quercetin presents a challenge for antimicrobial activity
because interaction of quercetin with microorganisms is
* Correspondence: serapacar5@gmail.com

difficult in aqueous media (Vashisth et al., 2013; Silva et
al., 2014).
Throughout the world, many researchers are
exploring efficient drug delivery vehicles that offer safe
and efficient transmission of therapeutic drugs (Stevanovic
and Uskokovic, 2009; Boimvaser et al., 2016). Poly(lacticco-glycolic acid) (PLGA) is one of the most effectively
developed biocompatible and biodegradable polymers
that can be utilized for medicine and pharmaceuticals
(Hans and Lowman, 2002; Kumari et al., 2010b). Recently,
several reviews have summarized the developments
of nanoencapsulation techniques and discussed the
important factors for bactericidal activity, such as the
influence of very small particle sizes and high surface-tovolume ratios (Derman et al., 2015). For biodegradable
polymeric nanoparticles, PLGA is an appropriate system
for encapsulation of antimicrobial compounds, especially
given the hydrophobic structure in consequence of
its high hydrophobicity (Kumari et al., 2010b), strong
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mechanical strength, slow drug release (Vashisth et al.,
2013), biodegradability, biocompatibility, and low toxicity.
Several natural compounds with antimicrobial activities
have been encapsulated in nanoparticles. For instance,
Gomes et al. (2011) stated that growth inhibition of
Salmonella spp. (gram-negative bacteria) and Listeria spp.
(gram-positive bacteria) was observed when eugenol and
trans-cinnamaldehyde-loaded PLGA nanoparticles (NPs)
were used at different concentrations between 10 and 20
mg/mL. Darvishi et al. (2015) reported that the minimum
inhibitory concentration (MIC) of 18-β-glycyrrhetinic
acid (GLA)-loaded NPs was approximately four times
lower for Pseudomonas aeruginosa, three times lower
for Staphylococcus epidermidis, and two times lower
for Staphylococcus aureus when compared to free GLA
solution regardless of the drug-to-polymer ratio. Pool et al.
(2012) showed that encapsulation of different flavonoids
in PLGA nanoparticle systems increased the antiradical
and chelating properties of quercetin and catechin (Pool
et al., 2012).
In the literature, the antimicrobial effect of quercetin
was assessed by using both gram-positive and gramnegative bacteria, and, in particular, selective antimicrobial
activity was revealed against S. epidermidis, S. aureus,
and methicillin-resistant S. aureus (MRSA) (Ramadan
et al., 2009; Hirai et al., 2010). Although quercetin has
been tested against gram-positive and gram-negative
bacteria and several studies have been published about
the antimicrobial properties of quercetin (Ramadan et al.,
2009; Hirai et al., 2010), its antimicrobial activity in PLGA
NP systems has not been clearly explained in terms of the
mechanism of microorganism inhibition, in which it plays
an essential role against pathogens (Nathiya et al., 2014).
Therefore, the aims of this work were to synthesize and
characterize quercetin-loaded
PLGA nanoparticles with different drug/polymer
ratios in detail and to assess the antimicrobial efficiency of
PLGA-loaded quercetin nanoparticles against foodborne
pathogens (Escherichia coli, Staphylococcus aureus,
Salmonella typhimurium, and Listeria monocytogenes).
For this purpose we synthesized highly stable and soluble
quercetin-encapsulated NPs using the oil-in-water (o/w)
single-emulsion solvent evaporation method. Quercetinloaded PLGA NPs differed from each other in terms of
encapsulation efficiency, reaction yield, particle size, and
polydispersity. Subsequently, to assess the antimicrobial
activity, agar well diffusion, broth dilution, and time-kill
assay methods were performed and the obtained results
were supported by scanning electron microscopy (SEM)
investigation of bacteria before and after exposure to NPs.
2. Materials and methods
Quercetin,
polyvinyl
alcohol
(PVA),
PLGA
(lactide:glycolide = 50:50; Mw ~ 38–54 kDa), and
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dichloromethane (DCM) were purchased from SigmaAldrich (St. Louis, MO, USA). For microbiological tests,
Mueller-Hinton broth (MHB) and Mueller-Hinton agar
(MHA) media (both from Difco, BD Diagnostic Systems,
Hunt Valley, MD, USA) were used. Listeria monocytogenes
(ATCC 35152), Salmonella typhimurium (ATCC 14028),
Staphylococcus aureus (ATCC 25923), and Escherichia coli
(ATCC 25922) were provided by the Atatürk University
Biology Department (Erzurum, Turkey).
2.1. Preparation of quercetin-loaded PLGA nanoparticles
In this study, nanoparticle preparation was carried out in
three different parts. In the first part, quercetin-loaded
nanoparticles were synthesized using three different
methods, which including nanoprecipitation, salting-out,
and single emulsion-solvent evaporation.
In the nanoprecipitation method (Budhian et al., 2007),
PLGA and quercetin were dissolved in 5 mL of acetone and
added to 50 mL of PVA (1% w/w) solution drop by drop.
In contrast to the second and third experiments, in the
first experiment (Q1 NP) external power was not applied.
On the other hand, in the second (Q2 NP) and third (Q3
NP) experiments, 120 s of sonication (80% amplitude)
and 5 min of homogenization at 24,000 rpm were applied,
respectively.
In the salting-out method (Sah and Sah, 2015), PLGA
and quercetin were dissolved in 5 mL of acetone and
added to 20 mL of PVA (2% w/w), which included 60%
MgCl2. For Q4 NP and Q5 NP, 120 s of sonication (80%
amplitude) and 5 min of homogenization at 24,000 rpm
were applied, respectively.
In the single emulsion-solvent evaporation method
(Derman, 2015), quercetin and PLGA were dissolved in
DCM (1.5 mL) and ethanol (0.750 mL), respectively (Q6
NP). The organic mixture was then emulsified with an
aqueous PVA solution (4 mL, 3% w/w). For emulsification,
120 s of sonication (80% amplitude) was applied, and then
this solution was added to PVA solution (35 mL, 0.1%
w/w).
In all experiments, 100 mg of PLGA and 10 mg of
quercetin were used and the organic solvent was removed
by mixing the solution at room temperature and 700 rpm
for 4 h. The obtained NPs were characterized in detail and
the best results were achieved with the single-emulsion
solvent evaporation method. Therefore, the optimization
study was carried out by o/w single-emulsion solvent
evaporation method.
In the second part, which was the optimization study
of single-emulsion solvent evaporation method, different
homogenization or sonication power (Table 1) was applied
for obtaining the water and aqueous phase emulsion. For
all syntheses, obtained NP suspensions were collected by
centrifugation at 12,000 rpm for 30 min at 4 °C. Thereafter,
the NPs were washed 3 times with ultrapure water to

Method

Nanoprecipitation

Nanoprecipitation

Nanoprecipitation

Salting-out

Salting-out

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Oil-in-water single emulsion

Sample

Q1 NPs

Q2 NPs

Q3 NPs

Q4 NPs

Q5 NPs

Q6 NPs

Q7 NPs

Q8 NPs

Q9 NPs

Q10 NPs

Q11 NPs

Q12 NPs

Q13 NPs

Q14 NPs

Q15 NPs

Q16 NPs

120

120

120

120

120

180

180

180

180

180

120

300

120

300

120

-

Time
(s)

-

-

-

-

-

3000

6000

12,000

18,000

24,000

-

24,000

-

24,000

-

-

Homogenization
speed (rpm)

100

80

60

40

20

-

-

-

-

-

80

-

80

-

80

-

Sonication
power (W)

76.7

74.5

89.8

87.6

75.4

67.1

67.0

66.9

64.9

55.2

86.8

51.7

74.5

56.5

76.2

50.1

RY (%)

91.7

92.1

95.3

94.3

93.9

95.1

95.1

91.9

90.1

88.2

89.1

44.7

63.6

72.7

78.2

75.7

EE (%)

479.55 ± 5

291.6 ± 7

403.2 ± 15

541.8 ± 2

763.05 ± 1

1138.5 ± 166

1101 ± 56

387.6 ± 11

329.2 ± 8

334.4 ± 8

529.3 ± 14

1107 ± 46

1906 ± 77

1457 ± 18

421.85 ± 28

297.75 ± 6

Particle size
(nm)

0.148 ± 0.080

0.245 ± 0.140

0.238 ± 0.015

0.151 ± 0.120

0.456 ± 0.010

0.403 ± 0.020

0.763 ± 0.300

0.188 ± 0.200

0.148 ± 0.003

0.228 ± 0.009

0.218 ± 0.020

0.324 ± 0.010

0.251 ± 0.004

0.256 ± 0.001

0.472 ± 0.008

0.211 ± 0.016

PDI

Table 1. The effect of different synthesis methods and synthesis parameters on encapsulation efficiency, reaction yield, particle size, PDI, and zeta potential .

–13.1 ± 0.6

–15.0 ± 0.2

–12.4 ± 1.2

–11.1 ± 1.0

–13.7 ± 4.2

–27.2 ± 0.8

–19.9 ± 0.2

–15.9 ± 0.1

–15.1 ± 0.1

–12.3 ± 0.2

–13.7 ± 0.8

–3.4 ± 0.2

–2.7 ± 0.1

–6.5 ± 0.1

–18.1 ± 0.8

–25.5 ± 1.2

Zeta potential
(mV)
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remove any unbound PVA and quercetin. Finally, the
pellets were freeze-dried and stored at –80 °C until used.
In the third part, three NP formulations with different
drug/polymer ratios (10/100, 30/100, and 50/100) were
synthesized for antimicrobial activity studies using
optimized process parameters. In the first formulation
(Q27 NP), 10 mg of quercetin was dissolved in ethanol
and 100 mg of PLGA was dissolved in DCM. The mixed
organic phase was emulsified in PVA solution by microtip
probe sonicator for 120 s (80% amplitude) and the
following preparation steps continued as described above.
The second and third formulations (Q29 NP and Q31 NP,
respectively) were prepared following the same procedure
as that for Q27 NP, except that 30 or 50 mg of quercetin
was used in these formulations instead of 10 mg. Free
nanoparticles were synthesized with the same protocol
without quercetin.
2.2. Characterization of polymeric nanoparticles
2.2.1. Reaction yield and encapsulation efficiency
To detect the encapsulation of quercetin, the amount of
quercetin within the solution obtained after centrifugation
was calculated using UV-Vis spectroscopy at 374 nm in
triplicate.
Quercetin concentration in the supernatant was
determined by comparing the concentration to a
previously constructed standard calibration curve. The
reaction yield (RY) and encapsulation efficiency (EE) of
quercetin-loaded nanoparticles were calculated using the
formulas given below.
EE % = (amount of quercetin encapsulated in NPs/
initial quercetin added) × 100
(1)
RY % = (amount of weighed NPs/amount of initial
PLGA+quercetin) × 100
(2)
2.2.2. Particle size, polydispersity index, and zeta
potential
Particle size (Z-Ave), polydispersity index (PDI), and zeta
potential (ζ) of the NPs were determined with photon
correlation spectroscopy using a Zetasizer Nano ZS
(Malvern Instruments, Worcestershire, UK) equipped
with 4.0 mV He-Ne laser (633 nm) (Derman, 2015). A 1/30
dilution of the fresh NP solution in distilled water at 25 ±
0.1 °C was used for measurements and each measurement
was performed in triplicate using 0.8872 cP viscosity and
1.330 refractive index for the solutions at a dielectric
constant of 79; f(ka), 1.50 (Smoluchowski value).
For determination of the zeta potential of bacterial cell
suspensions, overnight cultures of bacteria cell suspensions
were washed three times in 0.01 M sodium phosphate
buffer (pH 7.4), resuspended in PBS, and adjusted to
an OD600 of 0.1 in buffer. The zeta potentials of these
solutions were determined under similar conditions as
mentioned above.
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2.2.3. Scanning electron microscopy
SEM was used for visualization of the shape and size of
NPs. Freeze-dried NPs were fixed on metallic studs and
then coated with gold under a vacuum (Arasoglu et al.,
2015). A JSM-7001FA (JEOL, Tokyo, Japan) scanning
electron microscope was used with an acceleration voltage
of 7.00 kV.
Furthermore, the interactions of the NPs with bacterial
cells were examined using SEM. For this purpose, the
bacteria were incubated with the Q31 nanoparticles on
MHB for 24 h, then collected by centrifugation, washed
three times, and resuspended in 0.01 M sodium phosphate
buffer (pH 7.4). The cells were diluted (approximately 104
CFU/mL) and fixed on metallic studs. The SEM analyses
were carried out under similar conditions as mentioned
above.
2.2.4. In vitro quercetin release
The in vitro release profiles of Q27 NPs, Q29 NPs, and Q31
NPs were conducted to determine the release of quercetin
from the PLGA NPs according to a previously published
dissolution method (Derman et al., 2015). Lyophilized NPs
were suspended in the release medium, phosphate-buffered
saline with 0.01% sodium azide, and incubated at 37 °C in a
shaking incubator (60 rpm), from which at predetermined
time intervals up to 120 h (1, 2, 3, 4, 12, 24, 48, 72, 96,
and 120 h) medium was fully removed and analyzed for
quercetin contents. The quercetin concentration in the
supernatant was measured with UV-Vis spectroscopy at
374 nm by comparing the concentration to a previously
constructed standard calibration curve.
2.2.5. Evaluation of antibacterial activity
The antibacterial activity of the free quercetin and three
different quercetin NPs consisting of different drug/
polymer ratios (Q27, Q29, and Q31) was evaluated by three
different methods including agar well diffusion, broth
dilution, and time-kill assay for four different foodborne
microorganisms (Listeria monocytogenes, Salmonella
typhimurium, Staphylococcus aureus, Escherichia coli).
2.2.5.1. Preparation of bacterial suspensions
All strains were grown on MHB at 37 °C and 200 rpm
in a shaking incubator for an overnight period. The
bacterial cultures were diluted with sterile buffer solution
until the optical density was adjusted to 0.1 at 600 nm
(corresponding to 108 CFU/mL). This concentration was
used as the bacterial working dilution in the methods
applied in this study.
2.2.5.2. Evaluation of antibacterial activity by agar well
diffusion
The antimicrobial susceptibility tests of the free quercetin
and quercetin-loaded
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NPs (Q27 NPs, Q29 NPs, and Q31 NPs) were
performed as described previously by Irshad et al. (2012).
Briefly, petri plates were inoculated with bacterial cultures
and then wells were punched in the plates. After adding
100 µL of test sample to each well, petri plates were
aerobically incubated at 37 °C for 24 h. The concentrations
of samples were determined as 2 mg/mL for NPs and 0.225
mg/mL, 0.589 mg/mL, and 0.733 mg/mL for free quercetin
(based on the encapsulation efficiencies of the NPs). The
antimicrobial activity was evaluated by measuring the
inhibition zones surrounding wells (mm). Empty PLGA
nanoparticles and antibiotic disks (gentamicin, 10 µg/disk;
ofloxacin, 5 µg/disk; vancomycin, 5 µg/disk; ampicillin,
10 µg/disk) were used as negative controls and positive
controls, respectively.
2.2.5.3. Assessment of antibacterial activity according to
broth dilution method
This method was carried out in accordance with the
relevant 2012 CLSI standard (Cockerill et al., 2012). MIC
values of test samples were determined by broth dilution
method using micro- and macrodilution techniques.
In the microdilution method, 100 µL of test samples
(concentrations as mentioned in Section 2.2.5.2.) were
added to the first wells of 96-well plates after adding 95
µL of MHB to each well. Subsequently, 100 µL from their
serial dilutions was transferred to five consecutive wells
(ranging from 100 µg/mL to 3.125 µg/mL). The last three
wells were used as positive (ampicillin antibiotic solution),
negative (only bacteria), and blank (only broth) controls,
respectively. Finally, 5 µL from each bacterial suspension
was inoculated into wells (except blank control). The final
volume of each well was adjusted to 200 µL and then the
plate was incubated at 37 °C for 24 h. MIC values were
obtained spectrophotometrically at OD570 nm.
In the macrodilution method, eight tubes were prepared
to contain 8.0 mL of MHB, 1.0 mL of test samples (ranging
from 200 µg/mL to 3.125 µg/mL), and 1.0 mL of bacterial
working dilution for each sample and each bacterial
strain. After 24 h of incubation at 37 °C, a series of diluted
solutions were prepared from the test samples into tubes.
Each dilution was spread on MHA and incubated at 37 °C
for 24 h. The viable bacteria cells were counted. For each
bacterial strain, MIC values of free quercetin and quercetin
NPs were determined by correlated spectrophotometric
readings at OD570 nm and standard plate counts.
2.2.5.4. Evaluation of bacterial growth inhibition by
time-kill assay
This method was carried out based on ASTM standard E214913a (ASTM International, 2013). In this method, which is
designed under dynamic contact conditions and depends
on direct contact of bacteria with the drug, antimicrobial
activity of a test material is determined by shaking in a
bacterial working dilution depending on the time.

In brief, the test samples (concentrations as mentioned
in Section 2.2.5.2.) were put into tubes containing 50 mL
of MHB and then 0.5 mL of bacterial working dilution
was added and the mixture was incubated at 37 °C in a
shaking incubator. At selected time points (0 h, 3 h, 6 h, 24
h, 48 h, and 72 h), 100 µL of samples was spread on MHA
and then incubated 37 °C for 24 h. Viable colonies were
quantified. The results were evaluated in two ways, growthinhibiting efficiency and bactericidal activity, according to
the formulas below:
Growth-inhibiting efficiency, %, CFU/mL = ((B –
A)/B) × 100
(3)
Bactericidal activity, %, CFU/mL = ((C – A)/C) × 100
(4)
Here, A is CFU/mL for the flask containing the
quercetin-loaded nanoparticles after the predetermined
time, B is CFU/mL for the flask containing the free
quercetin after the predetermined time, and C is the initial
number of colonies in the culture broth containing only
bacteria.
2.2.6. Statistical analysis
All results were expressed as mean ± standard deviation.
SPSS 15.0 was used for statistical analyses (SPSS Inc.,
Chicago, IL, USA). ANOVA was applied for analyses of
variance and the difference between mean values was
compared by Tukey’s test. A level of probability of P < 0.05
was taken as indicating statistical significance (Özbek et
al., 2008).
3. Results
3.1. Characterization of nanoparticles
In this study, first, three different synthesis methods
including nanoprecipitation, salting-out, and o/w singleemulsion solvent evaporation were compared in terms
of encapsulation efficiency, reaction yield, particle size,
polydispersity index, and zeta potential.
After detailed characterization of nanoparticles, the o/w
single-emulsion solvent evaporation method was found
to be most effective based on EE. Thus, the o/w singleemulsion solvent evaporation method was used for the
preparation of quercetin-encapsulated nanoparticles. The
effect of homogenization (time and speed) and sonication
(time and power) processes on the NP characteristics
were studied in detail. All experimental conditions and
the obtained physicochemical properties of the quercetinencapsulated PLGA NPs are presented in Table 1.
3.2. Effect of synthesis method, homogenization speed,
and sonication power
In the present study, when we examined the results
of the three methods used for synthesis of quercetinencapsulated nanoparticles, the lowest particle size
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(297.75 ± 6 nm) was obtained by the nanoprecipitation
method with 50.1% RY and 75.7% EE. Otherwise, the best
RY (86.8%) and EE (89.1%) values were achieved with the
o/w single-emulsion method. In the salting-out method,
nanoparticles size were measured in micrometers. On the
other hand, in the nanoprecipitation method, application
of sonication was more effective than homogenization for
low particle size, high EE, and RY.
After achieving the best results with the single-emulsion
solvent evaporation method, this method was optimized
at different homogenization speeds (3000, 6000, 12,000,
18,000, and 24,000 rpm) and different sonication powers
(20, 40, 60, 80, and 100 W) on the basis of minimum
particle size, maximum encapsulation efficiency, and high
reaction yield (Table 1).
From the results, it was observed that homogenization
speed also plays a significant role on particle size and
encapsulation efficiency. A linear decrease in particle size
was observed with increasing homogenization speed. As
mentioned in the literature, high-speed homogenization
leads to increased shear force intensity, which overcomes
the intraforces acting in the particles (Quintanar-Guerrero
et al., 1996; Kushwaha et al., 2013). The encapsulation
efficiency and the reaction yield also decreased linearly
with decreasing homogenization speed. At 24,000 rpm
homogenization speed the RY and EE were calculated as
55.2% and 88.2%, respectively. These results, obtained in
parallel with the literature, were probably caused by the
decrease in particle size (Song et al., 2008a; Kushwaha et
al., 2013; Derman, 2015).
When examining the effect of sonication power, it can
be seen in Table 1 that the power of the sonication has a
remarkable effect on the particle size but has no significant
effect on encapsulation efficiency and reaction yield. The
particle size was significantly decreased by increasing
the sonication power (from 20 W to 80 W), and then
increased sharply for 100 W power of sonication. This
result indicates that sonication energy at 80 W for 120 s
was enough to resist the interfacial tension. A further
increase in sonication power (100 W) led to an increase
in particle size. This can be explained by the possible
increases of external energy leading to agglomeration of
the NPs (Halayqa and Domańska, 2014) and our results
are generally in agreement with the literature (Halayqa
and Domańska, 2014; Naeem et al., 2015). On the other
hand, both EE and RY first increased up to 60 W and then
decreased slowly at 80–100 W. When the particle size, EE,
and RY results were evaluated, it was concluded that best
results were achieved at 80 W.
Based on the best results for the lowest particle size
with high entrapment efficiency, the single-emulsion
solvent evaporation method with 80 W sonication power
for 120 s was chosen for synthesis of Q27, Q29, and Q31
NPs.
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3.3. Detailed characterization of Q27 NPs, Q 29 NPs,
and Q31 NPs
In this study we determined the RY, EE, size distribution,
zeta potential, and PDI for the detailed characterization
of Q27, Q29, and Q31 NPs. The results show that higher
reaction yield was achieved by increasing the initial
quercetin amount (Table 1). Additionally, in contrast
to the literature (Song et al., 2008b), the encapsulation
efficiency was increased by increasing the initial
quercetin amount and was calculated
as 93.4%, 96.2%, and 97.8% for Q27 NP, Q29 NP,
and Q31 NP, respectively.
Additionally, dynamic light scattering (DLS) results
showed that the sizes of the NPs are very close to
each other and vary from 244.3 ± 4 to 262.8 ± 7 nm.
Furthermore, PDI results showed that all NPs have
narrow particle size distribution with a small PDI value
(Figure 1; Table 1).
Moreover, SEM images of Q27 NPs, Q29 NPs, and
Q31 NPs (Figure 1) were in agreement with DLS results
and all NPs showed smooth and spherical shapes with
uniform particle distribution.
3.4. In vitro release study
In the present study, the in vitro release of optimized
NPs was carried out at pH 7.4 in PBS buffer for up to
120 h and the release profiles are shown in Figure 2.
The Q27, Q29, and Q31 NPs with different quercetin
contents (1.15 mg, 3.01 mg, and 3.70 mg, respectively)
presented a three-phasic release profile characterized
by burst release, lag phase, and sustained release. It
was observed in the release study that the certain
initial burst release increases as the quercetin content
increases.
In the first step of release, which was caused
by diffusion of the drug and continued for 4 h of
incubation, burst releases amounted to 0.39 mg, 1.08
mg, and 1.65 mg for Q27 NPs, Q29 NPs, and Q31
NPs, respectively. In the second phase, caused by drug
diffusion and cleavage of polymer chains, 0.98 mg,
2.33 mg, and 2.79 mg quercetin release was observed
for Q27 NPs, Q29 NPs, and Q31 NPs, respectively.
In the last step of quercetin release, a near-linear and
continuous release was observed over 72–120 h that
reached 0.95 mg (82.6%), 2.42 mg (80.4%), and 2.88
mg (77.8%), respectively, at the end of 120 h.
From the release results, it can be concluded that
the increase in encapsulated quercetin
in the particles affects the release profile such as
initial burst release or the cumulative amount of released
drug at any time. This situation has been described by
other researchers; the increase in encapsulated drug
increases the amount of drug close to the surface and in
the core of NPs (Budhian et al., 2008; Derman, 2015).
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Figure 1. Particle size distribution, SEM images, and physicochemical properties of Q27 NPs (A), Q29 NPs (B), and Q31 NPs (C).

3.5. Antibacterial activity of nanoparticles
3.5.1. Evaluation of antimicrobial activity by agar well
diffusion method
In this method, the antimicrobial potentials of free
quercetin and three different NPs were evaluated with
regard to their zone of inhibition against foodborne
pathogens. In the agar well diffusion method, none of the
test samples showed antimicrobial activity at the tested
concentrations (Figure 3). However, it was observed that
the low water solubility of quercetin was increased by
encapsulation in PLGA and the precipitate formation
was reduced in NP formulations (Figure 3).
3.5.2. Evaluation of antimicrobial activity by broth
dilution method
In this study, the MIC values of free quercetin and
quercetin-loaded nanoparticles were evaluated by micro-

and macrodilution techniques. In the broth microdilution
method, MIC values could not be determined
spectrophotometrically due to turbidity formation, which
gave absorbance at 570 nm caused by insoluble quercetin
compounds (data not shown).
The high optical density resulting from the increase in
turbidity is considered as bacterial growth in this method;
thus, it was detected that the free quercetin gave false
positive results by causing visible turbidity due to the
insolubility of quercetin. However, this situation was not
observed for quercetin-encapsulated PLGA NPs. There
is no doubt that NP systems are good solvent systems
as alternatives to other organic solvents such as ethanol,
methanol, and DMSO.
To obtain reliable MIC values in the broth macrodilution
method, standard plate counts were performed together
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Figure 2. Time-dependent release profile of different amount
quercetin encapsulated nanoparticles (Q27 NPs, Q29 NPs, and
Q31 NPs).

with spectrophotometric measurements at an OD of 570
nm (ELISA reader) for each strain. Table 2 shows the MICs
of quercetin and quercetin-loaded nanoparticles against
various foodborne pathogens. According to these results,
based on the increase in quercetin amounts, the MIC
value decreases and the antimicrobial activity increases.
However, it was observed that PLGA NP systems did
not cause a remarkable decrease in MIC values. Hence,
it was determined that there was no significant difference
between Q27, Q29, and Q31 NPs and free quercetin in
terms of MIC values, except for the decrease provided by
Q31 NPs against L. monocytogenes when compared to free
quercetin (respectively 100 µg/mL and 200 µg/mL). This
can be explained by the controlled and sustained release
of quercetin from NPs. In parallel with the literature (Hill
et al., 2013), a more sustained release of quercetin after
the initial burst gives rise to more inhibitory activity over
a longer period, and thus recovery time for damaged
pathogens during the initial burst is extended. As a result,
it was thought that the activity depends on the dose.
Additionally, MIC values of both quercetin-loaded NPs
and free quercetin were not determined at the tested
concentrations for E. coli and S. typhimurium.
3.5.3. Determination of antimicrobial activity by timekill assay
The time-kill studies were performed over a period of 72
h with bacteria being exposed to quercetin and its NP
formulations. In the time-kill assay, the decrease in the
number of bacterial colonies was interpreted as growthinhibiting or bactericidal activity. According to our results,
neither quercetin NP formulations nor free quercetin
showed bactericidal activity for any of the strains used
(data not shown). In addition, the test samples did not

134

Figure 3. The images obtained by agar well diffusion method of
the free quercetin and its nanoparticle formulations (Q27, Q29,
and Q31 NPs) against E. coli, S. aureus, L. monocytogenes, and S.
typhimurium pathogens.

show a significant inhibition effect on the growth of E.
coli and S. typhimurium bacteria when compared with
the control group containing bacteria only, nor on L.
monocytogenes and S. aureus.
Figure 4A shows that quercetin NPs (Q27 NPs, Q29
NPs, and Q31 NPs) have an inhibition effect on the
growth of L. monocytogenes. As shown in the figure, the
strongest inhibition effect was found with the Q31 NPs
(96.48%). Q27 NPs showed a 17.98% decrease in colony
counts compared to free quercetin after 6 h and this
value reached 63.48% at the end of the first day. However,
regrowth of 53.10% was observed after 48 h. For Q29
NPs, the decrease in bacterial counts due to the inhibition
effect of the NPs reached 85.78% on the first day and then
showed a gradual increase on subsequent days. However,
bacterial regrowth in the broth containing Q29 NPs was
observed to occur more slowly than in the broth with Q27
NPs. In the study performed with Q31 NPs, it was observed
that at end of the sixth hour antimicrobial activity began
(reaching 45.63%), then rose to over 96.48% on the first
day and lasted for 3 days.
Figure 4B demonstrates the time-kill curves of quercetin
NPs for S. aureus. As shown in the figure, Q29 NP and Q31
NP formulations of quercetin-loaded PLGA exhibited a
noticeable inhibition effect on the growth of S. aureus, but
the growth inhibition effect of Q31 NP was slightly higher
(a highest reduction rate of 79.12%) than that of Q29 NP
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Table 2. Minimum inhibitory concentration (MIC) of quercetin loaded nanoparticles (Q27 NP, Q29 NP, and Q31 NP) and free Quercetin
(at different amounts) agaınst foodborne pathogens through broth macrodilution method.

Test samples

Q27 NPs
Free Q for Q27 NPs
Q29 NPs
Free Q for Q29 NPs
Q31 NPs
Free Q for Q31 NPs

Drug/
polymer
ratio
10/100
30/100
50/100

MIC values (µg/mL)
Microorganisms
Listeria
monocytogenes

Salmonella
typhimurium

Escherichia coli

Staphylococcus
aureus

>200
>200
200
200
100
200

>200
>200
>200
>200
>200
>200

>200
>200
>200
>200
>200
>200

>200
>200
200
200
100
100

(a highest reduction rate of 53.70%). Q29 NPs showed a
30.77% drop in bacterial counts compared to free quercetin
at 6 h, and on the first day the reduction percentage reached
over 53.70 %, then decreased. For Q31 NPs, 38.40% growth
inhibition was achieved within 6 h. On the first day, this
increased to 79.12%. After that, it returned to the bacterial
growth stage while the inhibition rate decreased.
According to the results obtained with this method,
the antimicrobial activity related to growth inhibition
by quercetin NPs was slightly higher and longer for L.
monocytogenes than S. aureus.
3.5.4. Effect of bacterial surface charge on antimicrobial
activity of nanoparticles
In this study, bacterial surface charges of S. aureus, S.
typhimurium, L. monocytogenes, and E. coli were measured
at –13.1 ± 0.57 mV, –17.9 ± 0.62 mV, –7.04 ± 0.82 mV,

and –2.05 ± 0.12 mV, respectively. Surface charge results
showed that E. coli and S. typhimurium were significantly
more negatively charged than L. monocytogenes and S.
aureus. Additionally, L. monocytogenes was generally less
negatively charged than all other bacteria. For this reason,
L. monocytogenes presented a lower resistance and highest
susceptibility to the anionic NPs because the zeta potential
of Q31 NPs is –17.4 ± 1.0 mV.
3.5.5. Evaluation of bacteria cell integrity damaged by
quercetin nanoparticles
In the present study, the best antimicrobial activity was
observed for Q31 NPs against L. monocytogenes and S.
aureus. We therefore investigated the morphological changes
of these cells before and after exposure to Q31 NPs by SEM.
The obtained SEM micrographs of L. monocytogenes and S.
aureus cells are shown in Figure 5.

Figure 4. The time-dependent growth inhibition effect of quercetin nanoparticles on cell viability of L. monocytogenes (A) and
S. aureus (B) during 72 h of exposure. The growth inhibition % determined by Eq. (3) is a comparison of free quercetin and its
nanoparticle formulations (Q27, Q29, and Q31).
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Figure 5. Typical scanning electron microscope images of untreated L. monocytogenes (A), untreated S. aureus (B), quercetin
nanoparticle (Q31 NP)-treated L. monocytogenes (C), and quercetin nanoparticle (Q31 NP)-treated S. aureus (D).

Untreated L. monocytogenes cells were typically rodshaped (Figure 5A) and untreated S. aureus cells were
cocci bacteria, namely staphylococcal (Figure 5B), both
with smooth and intact cell walls. After 24 h of exposure to
Q31 NPs, the quantity of both strains greatly decreased in
parallel with the results of the time-kill assay. As observed
in the SEM images, the cell walls became wrinkled and
damaged, as in previous reports (Figures 5C and 5D)
(Tang et al., 2013; Li et al., 2015). However, it should be
noted that S. aureus cells that dispersed in a cluster were
destroyed as groups rather than individually due to the
antibacterial effect of quercetin NPs. Additionally, it can
be seen in Figures 5C and 5D that bacteria cells were
surrounded by Q31 NPs.
4. Discussion
In this research, the antimicrobial activity of quercetinencapsulated PLGA nanoparticles against four different
bacterial strains (Listeria monocytogenes, Salmonella
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typhimurium, Escherichia coli, and Staphylococcus aureus)
was evaluated by three different methods and using three
NP systems that differed in drug/polymer ratios (Q27 NPs,
Q29 NPs, and Q31 NPs).
According to the previous research in the literature, the
antibacterial mechanism of quercetin could be attributed
to the inhibition of nucleic acid synthesis, cytoplasmic
membrane function, bacterial cell wall synthesis, or energy
metabolism (Cushnie and Lamb, 2005; Hirai et al., 2010).
In this research, conducted with the purpose of increasing
antibacterial activity by encapsulating quercetin into a
NP system, the effects of the bacterial strains, methods,
and drug/polymer ratios on antimicrobial activity were
analyzed using the PLGA NP systems that are commonly
preferred in drug delivery.
First of all, it was realized that method selection is
extremely important because when the qualitative agar
well diffusion method was used, false negative results
were obtained. This could result from the insolubility of
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quercetin in water and its insufficient diffusion due to
its hydrophobic structure. However, in the literature it
has been shown by the agar well diffusion method that
quercetin molecules have antimicrobial activity. In these
studies, the antimicrobial activity study was carried out
after the solubility of free quercetin was enhanced using
different solvents such as methanol, DMSO, or ethanol
(Puupponen‐Pimiä et al., 2001; Ramadan et al., 2009).
This method works on the principle that antimicrobial
agents diffuse through the agar medium and therefore
it may give false results due to the lack of diffusion for
hydrophobic compounds (Darvishi et al., 2015). In the
research conducted by Park and Ikegaki (1998), the
effect of solvents on antimicrobial activity was evaluated
and it was determined that the solvent used directly
affects the antimicrobial activity results. Therefore, while
investigating the antimicrobial properties of compounds
with hydrophobic characteristics without using any
solvent, it is suggested that diffusion methods such
as agar well diffusion are not suitable (Arasoglu et al.,
2015; Wiegand et al., 2015). In broth dilution, one of the
qualitative methods, and especially in the microdilution
technique, it is thought that the formation of turbidity
due to low solubility of quercetin caused false readings
by spectrophotometer and a low total reaction volume
resulted in false negative results. The high optical density
resulting from the increase in turbidity is considered as
bacterial growth in this method; thus, it was detected that
the free quercetin gave false positive results by causing
visible turbidity due to the insolubility of quercetin. The
same result was observed by Sivaranjani et al. (2014). Thus,
high working volumes in the macrodilution technique that
is used for determining MIC values and in the time-kill
method that is used for evaluation of bacterial growth
by living cell counts have considerable influence over
antimicrobial activity results. The reason for this could
be the increase in bacteria–active substance surface
interaction when the volume is high. This is because,
especially in the time-kill method, quercetin-loaded
nanoparticles inhibited microbial growth more effectively
when compared to free quercetin. This could be because
of the high surface/volume ratio due to the relatively small
sizes of NP systems.
When choosing methods for antimicrobial activity
studies of PLGA NP systems, the physical and chemical
properties of active substances to be loaded into PLGA
should be in accordance with the working principles of
the method. Moreover, two or more methods should be
evaluated together. Nevertheless, when the literature was
reviewed it was seen that different antimicrobial activity
results were obtained from NP systems even though
chemical compounds and the methods used were the
same. The reasons for this could include parameters

such as methods that are not standardized, use of active
substances with different chemical compositions and
uncertain amounts of active substances encapsulated in
NPs, bacterial concentration, and total volume.
In this study, the antimicrobial activity results between
bacteria strains showed significant differences. The first
reason for this is the variation between the cell wall
structures of bacteria. In our study, it was shown that
quercetin and quercetin-loaded NPs have antimicrobial
activity only against gram-positive bacteria (Hirai et al.,
2010). The complex cell wall structure of gram-negative
bacteria acts as a barrier against quercetin and quercetinloaded nanoparticles (Nikaido, 1996; Duffy and Power,
2001; Ramadan et al., 2009; Espitia et al., 2012; Arasoglu et
al., 2015; Li et al., 2015; Suleiman et al., 2015). The second
reason is the differences in surface charges due to cell wall
structures of microorganisms (Croll et al., 2004; Dillen et
al., 2008; Rao, 2008; Rawlinson et al., 2011; Espitia et al.,
2012; Arasoglu et al., 2015). According to the zeta potential
results of our study, L. monocytogenes and S. aureus (–2.05
± 0.12 mV and –7.04 ± 0.82 mV) have more positive
surface charges than E. coli and S. typhimurium (–17.9
± 0.62 mV and –13.1 ± 0.57 mV). Synthesized quercetin
NPs have negative surface charges (zeta potential: –17.4
± 1.0 mV), so it was thought that their interaction with
microorganisms having a positive surface charge is stronger.
SEM images also supported this idea. The gathering of NPs
around clusters of bacteria is observed in these images.
Pore sizes of the cell membranes are also important
because it has been stated in the literature that due to the
smaller pore structure of E. coli than S. aureus (Sun et al.,
2016), penetration of active substances released from NPs
into cells is limited. The disruptive effect of intracellular
material released subsequent to the degradation of the
cell membrane is the third reason (Li et al., 2015). In SEM
images, the release of cytoplasmic constituents of damaged
bacteria cells into the environment and thus the formation
of translucent cytoplasm zones was observed. Accordingly,
we thought that quercetin NPs cause degradation of the
cell membrane by forming pores due to interaction with
the cell membrane and so intracellular matrix release from
cells led to cell death or damage.
Lastly, it was shown in our study that the drug/polymer
ratio affects the antimicrobial activity. While the MIC
value of Q27 NPs loaded with lower amounts of the drug
could not be determined at the tested concentrations, it
was observed that antimicrobial activity increased in
parallel with the drug ratio increase in Q29 and Q31 NPs.
Dose-related antimicrobial activity of quercetin, increase
in zeta potentials of NPs (Q31 NPs have the highest
antimicrobial activity and lowest negative zeta potential),
and time-dependent increase in released material amount
are the reasons for this. In particular, after the initial
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burst, a more consistent release of quercetin causes more
inhibitory activity over a longer period of time and thus
recovery time for pathogens damaged during the initial
burst is extended (Hill et al., 2013).
There are similarities and also some differences between
the antimicrobial activity results of our study and previous
research both for quercetin and quercetin NPs. Similar
results relating to antimicrobial activity of quercetin on
L. monocytogenes were found in a study conducted by
Vaquero et al. In that study, it was determined that the antiListeria activity of the flavonoid group including quercetin
and rutin was more effective than that of other flavonoid
groups and nonflavonoid groups (Vaquero et al., 2007;
Rodríguez Vaquero et al., 2011). Hirai et al. demonstrated
that quercetin possesses antibacterial activity against S.
aureus and S. epidermidis and significantly enhanced the
antibacterial activity of various antibiotics in the treatment
of MRSA. Similar results for E. coli were found by Hirai et
al., in which gram-positive cocci and gram-negative rods,
such as Streptococcus spp., P. aeruginosa, E. faecalis, and
E. coli, did not show susceptibility to any concentration of
quercetin (Hirai et al., 2010). Additionally, in the literature
free quercetin exhibits antimicrobial activity against several
bacterial species including Staphylococcus spp., Bacillus
spp., and Pseudomonas spp. (Ramadan et al., 2009; Hirai
et al., 2010). However, its effective concentrations for these
microorganisms were variable because of the fact that the
method selected for determination of antimicrobial effects
can influence the results obtained. Therefore, some of the
results related to quercetin in this study are consistent
with those obtained before. As indicated previously, it is
thought that the precipitation arising from the solvent
used in dissolving flavonoids is likely to cause diminished
contact between bacterial cells and flavonoid molecules
and may lead to false negative results of antibacterial
activity (Cushnie and Lamb, 2005). Our results differ
notably from the antimicrobial study of quercetin-loaded
PLGA nanoparticles performed by Sun et al. (2016). This
could be caused by differences in the methods used for
antimicrobial activity tests and nanoparticle synthesis,
solvents used for quercetin aside from water, amounts
of encapsulated quercetin in NPs, zeta potentials, and
release profiles. Hence, we thought that the consequential
differences of this and similar studies in the literature can
be reviewed much more effectively when standardized
methods are used or adequate method information is
given.
In conclusion, during the last decade, it has been
emphasized that encapsulation of active agents in PLGA
NP systems protects sensitive bioactive compounds,
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increases their solubility, and improves their bioavailability
in medicinal, pharmacological, and food industries.
Additionally, the factors that limit the use of quercetin
bioflavonoid, which is found in abundance in fruits and
vegetables consumed in daily human life, such as poor
water solubility, instability, absorption, and permeability,
were aimed to be overcome by encapsulating PLGA NP
systems in this study. Hence, highly monodispersed
quercetin-encapsulated PLGA NPs were successfully
developed by o/w single-emulsion solvent evaporation
and their antimicrobial activity was evaluated, compared
to free quercetin, on the foodborne pathogens L.
monocytogenes, S. typhimurium, E. coli, and S. aureus. The
antimicrobial activity of quercetin NPs and the effects of
the bacterial strains, methods, and drug/polymer ratios
on antimicrobial activity were investigated. According
to the results, quercetin-loaded PLGA NPs increased the
duration and effectiveness of antimicrobial activity only
against gram-positive bacteria.
Although the antimicrobial mechanism of quercetin
NPs has not been clearly
determined yet, their antimicrobial activity has been
attributed to three main factors: cell wall structure of
microorganisms, surface charges of microorganisms,
and the domino effect of the released intracellular matrix
from damaged or dead cells. Additionally, the increase in
zeta potentials of NPs and in time-dependently released
quercetin from NPs improved the antimicrobial activity of
quercetin NPs.
In addition, it was determined once again that
the method of selection in the antimicrobial studies
of PLGA NP systems is extremely important. However,
the factors that affect antimicrobial activity, such as NP
preparation methods, solvents of NPs or active agents,
zeta potential and sizes of particles, release properties
of NPs, antimicrobial activity methods, concentration
of NPs used, active ingredient amounts in NPs, and the
bacteria concentration used, should be stated. Thus, it
is considered that more realistic comparisons between
the same studies for antimicrobial activity of PLGA NP
systems can be achieved.
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